NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
-- On-track to report topline data from Phase 3 BROOKLYN trial in HeFH in 3Q 2024 and Phase 3 BROADWAY...
Pharmaceutical
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision...
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to...
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Worldwide collaboration agreement executed with Takeda Pharmaceuticals, including a $300 million upfront payment for rusfertide in polycythemia vera and other...
Red Light Holland to Export Its Largest Batch of Psilocybin to cGMP Lab in Canada, Under a 5th Health Canada Approved Psilocybin Import Permit to Partner CCrest Labs
Red Light Holland to export it's largest batch 5 kg (5000 grams) of Psilocybin Truffles, produced and sold in The...
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research
Conference In Dublin, Ireland on February 27 - 29, 2024Focuses on How to Bring Basic Science Discoveries to the Clinic...
ABVC’s New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
FREMONT, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing...
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a...
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
CORAL GABLES, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company...
AlzeCure Publishes its Year-end Report for January – December 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / February 27, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company...
Atena Equity Partners invests in cybersecurity and information technology group Redshift
The acquisition of a majority stake in the cybersecurity and information technology group, which boasted sales exceeding 12 million euros in...
HIGH Q TECHNOLOGIES SECURES $3.75 MILLION FROM GOVERNMENT OF CANADA TO SUPPORT EXPANSION OF PROTEIN MEASUREMENT PLATFORM FOR DRUG DISCOVERY
Funding through Government of Canada's Regional Quantum Initiative supports product development and commercialization efforts WATERLOO, ON, Feb. 26, 2024 /PRNewswire/...
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization
News Summary: Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved...
GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions
Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home CHICAGO...
MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies
LOS ANGELES, Feb. 26, 2024 /PRNewswire/ -- Today MAX BioPharma, Inc. (www.maxbiopharma.com) and Metaba, LLC (www.metaba.us) announced their collaboration in...
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:...
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member
Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that...
Gilead Sciences and Black HIV/AIDS Awareness Day: Taking Action Toward Meaningful Change
NORTHAMPTON, MA / ACCESSWIRE / February 26, 2024 / This year's theme for National Black HIV/AIDS Awareness Day is "Engage,...